First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial (Dr K K Aggarwal)                                                                                         (Dr RN Tandon)
To Read the full story on, or download our Android app or iOS app
29th April, 2017
Waist circumference a better indicator of health than BMI

A new study says that the waist circumference, and not body mass index (BMI), is a better indicator of increased risk of death from cardiovascular causes or any cause. 

In the study, normal weight individuals who had central obesity i.e. higher waist-to-hip ratio were at a 22% higher risk of death from any cause and a 25% higher risk for death from cardiovascular causes compared to these who are obese according to BMI but did not have central fat accumulation. The study jointly conducted by researchers from the University of Sydney in Australia and Loughborough University in England has been published April 26, 2017 in the Annals of Internal Medicine.

The body mass index is the most commonly used measure of obesity, which is based on height and weight of a person. It is calculated as weight (in kg) divided by the height squared (in cm). But, it does not measure body fat. The correct method to measure obesity is to measure body fat, especially the fat around the abdomen. A high waist-to-hip ratio indicates high amounts of abdominal fat.
To Read More or Comment, Click Here
Top News
Practice Updates
A new drug to treat liver cancer
Parkinson's disease may have its roots in the gut, says study
Women at greater risk for sports-related concussion
Energy drinks linked to more heart and BP changes than caffeinated drinks alone
Many patients with axial spondyloarthritis also have fibromyalgia
Study demonstrates long-term safety and tolerability of apremilast in psoriasis
Acupressure helps to reduce the symptoms of hyperemesis gravidarum in pregnant women
Risk of hypotension with administration of spinal-epidural anesthesia with hypobaric ropivacaine in sitting posting
Impact of high-intensity aerobic training on risk of type 2 diabetes and cardiovascular diseases in early and late premenopausal women
Comparing the efficacy of tension-free transobturator vaginal tape and autologous rectus fascia transobturator vaginal sling in reducing urinary incontinence in women
Apical sling and purse-string "neocervix" formation is an effective and safe method for the treatment of post-hysterectomy prolapse
eMedi Humor
Medicolegal Corner
eMedi Quiz
a) Complete proctocolectomy and Brook's ileostomy
b) Ileorectal anastomoses
c) Kock's pouch
d) Ileo anal pull-through procedure
Lifestyle Updates
Inspirational Story 1: Learn from your mistakes
Inspirational Story 2.The Doctor and the Father
Press Release
IMA lauds mandatory bioequivalence studies for drugs
Move will ensure that the manufactured drugs are safe and effective

New Delhi, April 28, 2017: In what can be called a long overdue move, the Ministry of Health and Family Welfare, has made bioequivalence studies compulsory for all drugs before they are launched in the Indian market. The draft amendments were first advertised in early February for public comment. Following this, the Drugs and Cosmetics Rules, 2017 were formally amended through a notification on April 3 to incorporate the change.
Bioequivalence studies are conducted to establish that both the original patented drug and a generic version of it have the same biological equivalence. This means they should work the same way, to the same extent, and for the same purpose. Welcoming this move, Padma Shri Awardee Dr K K Aggarwal, National President Indian Medical Association (IMA) and President Heart Care Foundation of India (HCFI) and Dr RN Tandon - Honorary Secretary General IMA in a joint statement, said, "For a long time, doctors have been prescribing generic drugs with no data on how these would perform.
To Read More or Comment, Click Here
IMA Updates